Evidence map›Paper›PMID 24813298›Full record

GuidelineJournal of the American Academy of Dermatology2014

Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.

Robert Sidbury, Dawn M Davis, David E Cohen, Kelly M Cordoro, Timothy G Berger, James N Bergman, Sarah L Chamlin, Kevin D Cooper, Steven R Feldman, Jon M Hanifin and 14 more

Open access · greenAbstract readPractice Guideline
In one paragraph

Guideline in Journal of the American Academy of Dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 285 papers, 15 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
285citing papers in PubMed, 15 pooled it
56.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

285 citing papers in PubMed, 15 syntheses or guidelines pooled it, 861 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Phototherapy for atopic eczema.The Cochrane database of systematic reviews · 2021
    Pooled it
  12. Pooled it
  13. Systemic treatments for eczema: a network meta-analysis.The Cochrane database of systematic reviews · 2020
    Pooled it
  14. Pooled it
  15. Pooled it
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

225 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 17 institutions in 4 countries.

Robert SidburyDepartment of Dermatology, Seattle Children's Hospital, Seattle, Washington.
Dawn M DavisDepartment of Dermatology, Mayo Clinic, Rochester, Minnesota.
David E CohenDepartment of Dermatology, New York University School of Medicine, New York, New York.
Kelly M CordoroDepartment of Dermatology, University of California, San Francisco, California.
Timothy G BergerDepartment of Dermatology, University of California, San Francisco, California.
James N BergmanDepartment of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
Sarah L ChamlinDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Kevin D CooperDepartment of Dermatology, Case Western University, Cleveland, Ohio.
Steven R FeldmanDepartment of Dermatology, Wake Forest University Health Sciences, Winston-Salem, North Carolina.
Jon M HanifinDepartment of Dermatology, Oregon Health and Science University, Portland, Oregon.
Alfons KrolDepartment of Dermatology, Oregon Health and Science University, Portland, Oregon.
David J MargolisDepartment of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
Amy S PallerDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Kathryn SchwarzenbergerKaplan-Amonette Department of Dermatology, University of Tennessee Health Science Center, Memphis, Tennessee.
Robert A SilvermanPrivate practice, Fairfax, Virginia.
Eric L SimpsonDepartment of Dermatology, Oregon Health and Science University, Portland, Oregon.
Wynnis L TomUniversity of San Diego, San Diego, California; Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital, San Diego, California.
Hywel C WilliamsCenter of Evidence-based Dermatology, Nottingham University Hospitals National Health Service Trust, Nottingham, United Kingdom.
Craig A ElmetsDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama.
Julie BlockNational Eczema Association, San Rafael, California.
Christopher G HarrodAmerican Academy of Dermatology, Schaumburg, Illinois.
Wendy Smith BegolkaAmerican Academy of Dermatology, Schaumburg, Illinois. Electronic address: wsmithbegolka@aad.org.
Lawrence F EichenfieldUniversity of San Diego, San Diego, California; Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital, San Diego, California.
American Academy of Dermatology
Oregon Health & Science University · USAmerican Academy of Dermatology · USNorthwestern University · USUniversity of California, San Francisco · USUniversity of San Diego · USCalifornia University of Pennsylvania · USCase Western Reserve University · USIS practice · BEMayo Clinic · USNational Eczema Association · USNational Health Service · GBNew York University · USSeattle Children's Hospital · USUniversity of Alabama at Birmingham · USUniversity of British Columbia · CAUniversity of Tennessee Health Science Center · USWake Forest University · US

Funding

Vitamin D endocrine system and Protection Against Skin TumorlgenesisP30AR039750 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI COOPER, KEVIN D · 1988 to 2015
$9.1M
Genetic Influence in Pediatric PsoriasisK23AR060274 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TOM, WYNNIS L · 2011 to 2015
$663k
Department of Health RP-PG-0407-10177NIAMS NIH HHS K23 AR060274NIAMS NIH HHS K23AR060274NIAMS NIH HHS P30 AR039750
6 · The paper itself

Abstract

Atopic dermatitis is a chronic, pruritic inflammatory dermatosis that affects up to 25% of children and 2% to 3% of adults. This guideline addresses important clinical questions that arise in atopic dermatitis management and care, providing recommendations based on the available evidence. In this third of 4 sections, treatment of atopic dermatitis with phototherapy and systemic immunomodulators, antimicrobials, and antihistamines is reviewed, including indications for use and the risk-benefit profile of each treatment option.

Indexed as

PhototherapyAnti-Infective AgentsAzathioprineCyclosporineDermatitis, AtopicHistamine AntagonistsHumansImmunologic FactorsInterferon-gammaMethotrexateMycophenolic AcidAnti-Infective AgentsAzathioprineCyclosporineHistamine AntagonistsImmunologic FactorsInterferon-gammaMethotrexateMycophenolic Acidatopic dermatitisazathioprinecyclosporin Ainterferon gammamethotrexatemycophenolate mofetiloral antihistaminesoral antimicrobialsoral steroidsphotochemotherapyphototherapysystemic therapy

Identifiers

PMID24813298
PMCPMC4410179
OpenAlexW189068515

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.